Similarly, high dosages (0.6–1.0 g) of NAC administered orally three times daily for 4 weeks to patients with cystic fibrosis increased neutrophil GSH levels and reduced airway inflammation (neutrophil migration in airways, elastase activity, and IL-8 levels) [71]. This evidence concerns the gene CXCL8 and cystic fibrosis.